Brind.

Aldevron, a company owned by Danaher, is expanding into the Boston biotech corridor.

1 report, 1 independent Updated Jul 30

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Danaher Corporation Aldevron

Keep exploring

The entities involved

Danaher Corporation
American conglomerate
- Sidharth Kapileshwar joins MaxCyte as Chief Corporate Development Officer after leaving Danaher Corporation.Wed 14:03
- MarketBeat listed Danaher, Dexcom, Medtronic, Gilead Sciences, and Boston Scientific as stocks to watch on September 22, 2026.Tue 20:16
Aldevron
company in Fargo, United States

Nothing else this week.

Coverage

Newest first; wire copies grouped

Jul 30Business WireAldevron Launches New Innovation Center in Waltham, MA Strategic expansion places Aldevron at the heart of the Boston biotech corridor, fueling next-generation breakthroughs in genomic medicine FARGO